Glioblastoma and Individualized Therapies
ConditionGlioma, Malignant
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorZentrum fur Humangenetik Tuebingen
About this trial
The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
malignant glioma, IDH WT
Disqualifiers
na
Trial design
Treatments tested in this trial
Vaccination
Biological/VaccinePersonalized neoantigen vaccination
Treatment groups
No treatment groups listed
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov